March 31, 2021 Cures Within Reach Names CURE ID as 2021 Patient Impact Awardee Cures Within Reach, a global nonprofit leading the use of repurposing research to help improve patients’ lives, has a
March 31, 2021 Introducing Dr. Alexandre Bétourné, RDCA-DAP Scientific Director C-Path is pleased to welcome Alexandre Bétourné, PhD, PharmD, as its new Scientific Director for the Rare Disease Cures Accelera
March 25, 2021 C-Path Launches Acute Kidney Injury Project with Support from FDA Project aims to develop improved predictive and detection tools for kidney injury TUCSON, March 25, 2021 — Acute kidney injury (
March 20, 2021 Current state of cardiac troponin testing in Duchenne muscular dystrophy cardiomyopathy: review and recommendations from the Parent Project Muscular Dystrophy expert panel
March 19, 2021 C-Path Names COO Kristen Swingle Interim President Joseph Scheeren departing the organization after two years of strong leadership TUCSON, Ariz., March 19, 2021 — Critical Path In
March 18, 2021 Welcome Dr. Martijn Muller as CPP Senior Scientific Director C-Path is pleased to welcome Martijn Muller, PhD, as Senior Scientific Director for the Critical Path for Parkinson Consortium. Pr
March 18, 2021 A metadata-driven tool to determine the robustness of digital health technologies assessments for Parkinson’s Disease leveraging the voice of the patient – Sakshi Sardar, et al. Abstract # 1314
March 18, 2021 Metadata standards to support deployment of Digital Health Technologies in Clinical Trials in Parkinson’s Disease – Derek Hill, et al. Abstract # 1289
March 18, 2021 Identifying and Controlling Variability in Digital Health Measures in Parkinson’s Disease Clinical Trials – George Roussos, et al. Abstract # 342